KATHRYN E FALBERG

CIK 1206977 · EVP and CFO · last filed 2026-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$38.83M

Companies

15

Total Filings

126

Lifetime Open-Market Net

-$70.27M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RCUS Director 176,406 $26.46 $4.67M $1.55M 13 2026-06-12
NUVB Director $6.46 $0 1 2026-05-26
TTD Director 212 $19.10 $4.0K -$73.56M 24 2026-03-25
Nuvation Bio Inc. (NUVB.WS) Delisted Director 75,041 $0.01 $383 $483.8K 8 2025-05-23
Tricida, Inc. (TCDA) Delisted Director 59,163 $0.11 $6.4K $600.0K 5 2022-06-16
URGN Director $40.51 $0 3 2021-06-09
COLL Director 0 $36.17 $0 $960.0K 7 2020-10-14
BMRN Director 2,640 $61.35 $162.0K $0 2 2016-09-01
MEDIVATION, INC. (MDVN) Delisted Director 82,742 $2.94M 7 2016-06-23
LIFE Director $19.66 $0 3 2016-05-26
HALOZYME THERAPEUTICS, INC. (HTI) Delisted Director 358,253 $942.1K 12 2016-05-06
Aimmune Therapeutics, Inc. (AIMT) Delisted Director 94,894 $400.0K 1 2015-08-11
JAZZ EVP and CFO 133,387 $254.86 $34.00M -$4.52M 27 2014-03-06
QLTI Director $26.95 $0 3 2011-05-27
Oruka Therapeutics, Inc. (ABIO) Delisted CFO and COO 1 $28.80 $29 -$75.9K 3 2009-06-26

Recent Filings · Page 4 of 13

126 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-06-11 Tricida, Inc. (TCDA) Delisted Grant (A) +16,403 $0 EDGAR
2021-06-09 URGN Grant (A) $0 EDGAR
2021-06-07 RCUS Grant (A) +3,000 $0 EDGAR
2021-06-01 TTD Grant (A) +500 $70.4K EDGAR
2021-04-02 RCUS Buy (P) +20,000 $567.0K EDGAR
2021-02-12 Nuvation Bio Inc. (NUVB.WS) Delisted Grant (A) $0 EDGAR
2020-11-23 TTD Mixed -$16.26M EDGAR
2020-10-14 COLL Mixed −142,926 -$4.93M EDGAR
2020-06-15 Tricida, Inc. (TCDA) Delisted Grant (A) +5,670 $0 EDGAR
2020-06-10 URGN Grant (A) $0 EDGAR
Showing 3140 of 126
Page 4 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.